PANACEA INNOVATION LTD sold 23.7% of their position (313.45K shares) of ATARA BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $3.17M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/11/2026ACC: 0001193125-26-217380
10% Owner
Since Mar 2026
-313.45K
Net shares
Net seller
$3.17M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
313.45K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−313.45K
Price / share
$10.10
Trade value
$3.17M
% of position
23.7%
5/7/2026
1.32M→1.01M
Total
Net shares
−313.45K
Net value
-$3.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/7/2026 | S · Sale | −313.45K | $10.10 | $3.17M | 23.7% | 1.32M | 1.01M |
| Total | −313.45K | -$3.17M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned307.89K
Total
307.89K indirect307.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 307.89K | Indirect |
| Total | 307.89K | 307.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported